Cole P
Thomson Reuters, Barcelona, Spain.
Drugs Today (Barc). 2016 Sep;52(9):531-534. doi: 10.1358/dot.2016.52.9.2550577.
GTCBio's Precision Medicine Conference met this year to outline the many steps forward that precision medicine and individualized genomics has made and the challenges it still faces in technological, modeling, and standards development, interoperability and compatibility advancements, and methods of economic and societal adoption. The conference was split into four sections, 'Overcoming Challenges in the Commercialization of Precision Medicine', 'Implementation of Precision Medicine: Strategies & Technologies', 'Integrating & Interpreting Personal Genomics, Big Data, & Bioinformatics' and 'Incentivizing Precision Medicine: Regulation & Reimbursement', with this report focusing on the final two subjects.
GTC生物公司的精准医学会议于今年召开,概述了精准医学和个性化基因组学取得的诸多进展,以及在技术、模型和标准开发、互操作性和兼容性提升,以及经济和社会应用方法等方面仍面临的挑战。会议分为四个部分,即“克服精准医学商业化中的挑战”“精准医学的实施:策略与技术”“整合与解读个人基因组学、大数据与生物信息学”以及“激励精准医学:监管与报销”,本报告聚焦于最后两个主题。